Dozens of bewildered tourists were kicked out of a Hong Kong hotel after it was taken over by a city bank due to an unpaid loan, a report said yesterday.
The visitors from Taiwan, Australia, Malaysia, Singapore, Denmark, Italy, Argentina and China were ordered to leave the Tatami Hampton Hotel after Bank of East Asia (BEA, 東亞銀行) took possession of the property, according to the South China Morning Post.
“How could something like this happen in Hong Kong?” a woman from China who identified herself as Li was quoted as saying by the newspaper.
Li learned of the problem when she arrived in Hong Kong on Wednesday evening with her three teenage daughters and was told she could not stay in the hotel, located in the city’s Mongkok area, the report said.
The move comes after a prolonged battle between BEA and Labour Buildings, the company that runs the hotel, over an unpaid HK$80 million (US$10.2 million) loan.
The company, a former investment arm of Taiwan’s Chinese Nationalist Party (KMT), said it was granted the loan to curry favor with the ruling party 10 years ago, according to the newspaper.
A notice posted in the hotel lobby said it had been taken over by lawyers representing the bank and the bailiff pursuing a court order, the report said. TV images showed the hotel doors bolted shut.
A BEA spokeswoman said it had no immediate comment.
Hong Kong was hit by a string of tourism scandals last year, when visitors on cheap package deals were forced to visit certain stores and encouraged to buy goods before being allowed to leave.
KEEPING UP: The acquisition of a cleanroom in Taiwan would enable Micron to increase production in a market where demand continues to outpace supply, a Micron official said Micron Technology Inc has signed a letter of intent to buy a fabrication site in Taiwan from Powerchip Semiconductor Manufacturing Corp (力積電) for US$1.8 billion to expand its production of memory chips. Micron would take control of the P5 site in Miaoli County’s Tongluo Township (銅鑼) and plans to ramp up DRAM production in phases after the transaction closes in the second quarter, the company said in a statement on Saturday. The acquisition includes an existing 12 inch fab cleanroom of 27,871m2 and would further position Micron to address growing global demand for memory solutions, the company said. Micron expects the transaction to
Nvidia Corp’s GB300 platform is expected to account for 70 to 80 percent of global artificial intelligence (AI) server rack shipments this year, while adoption of its next-generation Vera Rubin 200 platform is to gradually gain momentum after the third quarter of the year, TrendForce Corp (集邦科技) said. Servers based on Nvidia’s GB300 chips entered mass production last quarter and they are expected to become the mainstay models for Taiwanese server manufacturers this year, Trendforce analyst Frank Kung (龔明德) said in an interview. This year is expected to be a breakout year for AI servers based on a variety of chips, as
Global semiconductor stocks advanced yesterday, as comments by Nvidia Corp chief executive officer Jensen Huang (黃仁勳) at Davos, Switzerland, helped reinforce investor enthusiasm for artificial intelligence (AI). Samsung Electronics Co gained as much as 5 percent to an all-time high, helping drive South Korea’s benchmark KOSPI above 5,000 for the first time. That came after the Philadelphia Semiconductor Index rose more than 3 percent to a fresh record on Wednesday, with a boost from Nvidia. The gains came amid broad risk-on trade after US President Donald Trump withdrew his threat of tariffs on some European nations over backing for Greenland. Huang further
Sweeping policy changes under US Secretary of Health and Human Services Robert F. Kennedy Jr are having a chilling effect on vaccine makers as anti-vaccine rhetoric has turned into concrete changes in inoculation schedules and recommendations, investors and executives said. The administration of US President Donald Trump has in the past year upended vaccine recommendations, with the country last month ending its longstanding guidance that all children receive inoculations against flu, hepatitis A and other diseases. The unprecedented changes have led to diminished vaccine usage, hurt the investment case for some biotechs, and created a drag that would likely dent revenues and